Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Maintenance Treatment
.
Show all posts
Showing posts with label
Maintenance Treatment
.
Show all posts
Monday, October 7, 2024
FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)
›
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces the US Food and Drug Administration (“FDA”) approved Ohtuvayr...
›
Home
View web version
